Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Brooklyn ImmunoTherapeutics LLC Brooklyn ImmunoTherapeutics Acquires License for mRNA Technology Platform to Develop Genetically Edited Cells to Treat Multiple Cancers, Blood and Other Disorders April 29, 2021 From Brooklyn ImmunoTherapeutics LLC Via Business Wire Tickers BTX Brooklyn ImmunoTherapeutics Reports Inducement Grants April 19, 2021 From Brooklyn ImmunoTherapeutics LLC Via Business Wire Tickers BTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.